Immunogenicity and Safety of Menactra® Vaccine in Subjects Aged 9 to 23 Months in India and in the Russian Federation

NCT01890759 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningitis
Meningococcal Infection

Interventions

BIOLOGICAL: Meningococcal Diphtheria Toxoid Vaccine

Sponsor

Sanofi Pasteur, a Sanofi Company